Showing results (1901-1910 of 2,011) with videos related to

Sort By:
Pageof 202
BJU International|January 5, 2020
The ProtecT trial: analysis of the patient cohort, baseline risk stratification and disease progressionRichard J Bryant, Jon Oxley, Grace J Young, et al.
Biorxiv : the Preprint Server for Biology|March 27, 2026
Comparison of Galleria mellonella , Epithelial Cell Cytotoxicity, and Mouse Model of Bacteremia to Measure Pseudomonas aeruginosa VirulenceAliki Valdes, Christopher Axline, Travis J Kochan, et al.
Immunity|July 28, 2023
Human anti-N1 monoclonal antibodies elicited by pandemic H1N1 virus infection broadly inhibit HxN1 viruses in vitro and in vivoLena Hansen, Meagan McMahon, Hannah L Turner, et al.
Ambio|December 4, 2004
Environmental changes in the North Atlantic Region: SCANNET as a collaborative approach for documenting, understanding and predicting changesTerry V Callaghan, M Johansson, O W Heal, et al.
PLOS Global Public Health|July 2, 2024
A cluster-randomized trial of client and provider directed financial interventions to align incentives with appropriate case management in private medicine retailers: Results of the TESTsmART trial in Lagos, NigeriaTheodoor Visser, Jeremiah Laktabai, Emmah Kimachas, et al.
Nature Medicine|February 19, 2020
Engineered immunogen binding to alum adjuvant enhances humoral immunityTyson J Moyer, Yu Kato, Wuhbet Abraham, et al.
ACS Medicinal Chemistry Letters|September 27, 2017
Correction to "Discovery of Fevipiprant (NVP-QAW039), a Potent and Selective DP2 Receptor Antagonist for Treatment of Asthma"David A Sandham, Lucy Barker, Lyndon Brown, et al.
Bioorganic & Medicinal Chemistry Letters|May 29, 2007
2-Cycloalkyl phenoxyacetic acid CRTh2 receptor antagonistsDavid A Sandham, Clive Aldcroft, Urs Baettig, et al.
Biorxiv : the Preprint Server for Biology|February 23, 2026
SenNet Portal: Build, Optimization and UsageKaty Börner, Philip D Blood, Jonathan C Silverstein, et al.
JAMA|April 6, 2024
Prostate-Specific Antigen Screening and 15-Year Prostate Cancer Mortality: A Secondary Analysis of the CAP Randomized Clinical TrialRichard M Martin, Emma L Turner, Grace J Young, et al.
Pageof 202